| P2093 | author name string | Lee M | |
| | Naeim F | |
| | Schiller G | |
| | Emmanoulides C | |
| | Iastrebner MC | |
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| | Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 |
| | Reporting results of cancer treatment | Q29620070 |
| | Susceptibility of acute myeloid leukemia (AML) cells from clinically resistant and sensitive patients to daunomycin (DNR): assessment in vitro after stimulation with colony stimulating factors (CSFs). | Q34553480 |
| | Treatment of resistant acute myeloid leukemia | Q36933678 |
| | Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment | Q37909059 |
| | Treatment strategies in acute myeloid leukemia (AML). A. First-line chemotherapy | Q38140944 |
| | Improved prognosis in mice with advanced myeloid leukemia following administration of GM-CSF and cytosine arabinoside | Q41700867 |
| | Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial | Q44071327 |
| P433 | issue | 5-6 | |
| P921 | main subject | cytarabine | Q180983 |
| P304 | page(s) | 427-434 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia | |
| P478 | volume | 20 | |